Clinical Trial Update: Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating preoperative neoadjuvant immunotherapy combined with chemotherapy for stage III unresectable non-small cell lung cancer is ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: The Affiliated Hospital of Qingdao University | Conditions: Non-small-cell Lung Cancer (NSCLC) | Phase 4 | Status: RECRUITING